Olivier Muller

Showing 1-14 of 14 articles

A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial

Iglesias JF, Muller O, Zaugg S, Roffi M, Kurz D, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, Jüni P, Windecker S, Pilgrim T

August 24, 2018 | 10.4244/EIJ-D-17-00734

Interventions for valvular disease

Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

Seiffert M, Treede H, Schofer J, Linke A, Wöhrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Muller O, Whisenant B, Thukkani A, Weisz G, Dvir D

July 20, 2018 | 10.4244/EIJ-D-17-00546

Interventions for valvular disease

How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic transcatheter aortic valve implantation?

Fournier S, Monney P, Roguelov C, Ferrari E, Eeckhout E, Muller O, Durko A, Van Mieghem N, Kappetein AP, Margey R

July 20, 2017 | 10.4244/EIJ-D-16-00592

Coronary interventions

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S

December 9, 2016 | 10.4244/EIJY15M12_09

Coronary interventions

Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial

Franzone A, Taniwaki M, Rigamonti F, Heg D, Piccolo R, Roffi M, Tüller D, Muller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Jüni P, Windecker S, Pilgrim T

August 5, 2016 | 10.4244/EIJV12I5A99

Coronary interventions

How should I treat a coronary artery fistula complicated with myocarditis – PCI or surgery?

Morawiec B, Muller O, Khatchatourov G, Goy J-J, Qureshi S, Silaschi M, Wendler O

June 10, 2016 | 10.4244/EIJV12I2A45

Tools & Techniques: The year of the textbook – time to say good-bye!

Naber C, Sachdev B, Muller O, Eeckhout E, Fajadet J

May 15, 2012 | 10.4244/EIJV8I1A24

AsiaPCR/SingLive: in its third year and growing

Lim E, Lim C, Muller O, Yeo KK, Lim S-T, Koh T-H, Eeckhout E

February 21, 2012 | 10.4244/EIJV7I10A184

Complications with a happy ending

Muller O, Lerman A, Eeckhout E

December 30, 2011 | 10.4244/EIJV7I8A141

Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study

Puricel S, Adorjan P, Oberhänsli M, Stauffer J-C, Moschovitis A, Vogel R, Goy J-J, Muller O, Eeckhout E, Togni M, Wenaweser P, Meier B, Windecker S, Cook S

October 28, 2011 | 10.4244/EIJV7I6A112

Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction

Muller O, Delrue L, Hamilos M, Vercauteren S, Ntalianis A, Trana C, Mangiacapra F, Dierickx K, De Bruyne B, Wijns W, Behfar A, Barbato E, Terzic A, Vanderheyden M, Bartunek J

August 30, 2011 | 10.4244/EIJV7I4A75

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update

Cuisset T, Valgimigli M, Mudra H, Muller O, Wijns W, Huber K

May 25, 2010

Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations

Muller O, Windecker S, Cuisset T, Fajadet J, Mason M, Zuffi A, Doganov A, Eeckhout E

August 20, 2008

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions

Cuisset T, Mudra H, Muller O, Vogt P, Angelillo-Scherrer A, Huber K

August 20, 2008

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Paravalvular leak after TAVI & TAVI with ACURATE NEO

January 7, 2020

Olivier Muller

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke